Can-Fite BioPharma's quoted shares on this page are American Depository Receipts (ADRs) which are negotiable certificates issued by a U.S. bank representing a specified number of Can-Fite's ordinary shares which are traded on the Tel Aviv Stock Exchange. The ratio is 1 ADR = 2 ordinary shares. Can-Fite currently has approximately 8.06 million ADRs traded on the NYSE.
Although the ADR share price reflected on this page from QuoteMedia is correct, the total number of ADRs listed may not be correct, and therefore the market capitalization and any other number associated with the number of ADRs issued may not be correct. The correct way to calculate Can-Fite's market capitalization is to multiply the number of ADRs issued, approximately 8.06 million, by the current day's ADR price. We are currently working with QuoteMedia to have their streaming media corrected and updated.